Marketers Barred from Making Deceptive Claims that their Product, iV Cocktails, Can Treat Serious Diseases and Produce Fast, Long‐Lasting Results

The Federal Trade Commission today, for the first time, charged a marketer and seller of intravenously injected therapy products (iV Cocktails) with making a range of deceptive and unsupported health claims about their ability to treat serious diseases such as cancer, multiple sclerosis, and congestive heart failure. The proposed FTC order settling the claims prohibits the company, which operates a string of clinics in north Texas; New Braunfels, Texas; and Vail, Colorado, and its owner from making such claims, unless they can be supported by competent and reliable scientific
evidence.

PRO TIP: Health claims must be supported by competent and reliable scientific evidence.